- Home
- VGI vs GNLX Comparison
VGI vs GNLX Comparison
Compare VGI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGI
- GNLX
- Stock Information
- Founded
- VGI 2012
- GNLX 2001
- Country
- VGI United States
- GNLX United States
- Employees
- VGI N/A
- GNLX N/A
- Industry
- VGI Investment Managers
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- VGI Finance
- GNLX Health Care
- Exchange
- VGI Nasdaq
- GNLX Nasdaq
- Market Cap
- VGI N/A
- GNLX 96.6M
- IPO Year
- VGI N/A
- GNLX 2023
- Fundamental
- Price
- VGI $7.88
- GNLX $2.86
- Analyst Decision
- VGI
- GNLX Strong Buy
- Analyst Count
- VGI 0
- GNLX 4
- Target Price
- VGI N/A
- GNLX $17.75
- AVG Volume (30 Days)
- VGI 46.0K
- GNLX 145.0K
- Earning Date
- VGI 01-01-0001
- GNLX 08-13-2025
- Dividend Yield
- VGI 12.66%
- GNLX N/A
- EPS Growth
- VGI N/A
- GNLX N/A
- EPS
- VGI N/A
- GNLX N/A
- Revenue
- VGI N/A
- GNLX N/A
- Revenue This Year
- VGI N/A
- GNLX N/A
- Revenue Next Year
- VGI N/A
- GNLX N/A
- P/E Ratio
- VGI N/A
- GNLX N/A
- Revenue Growth
- VGI N/A
- GNLX N/A
- 52 Week Low
- VGI $6.68
- GNLX $1.60
- 52 Week High
- VGI $7.99
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- VGI 67.63
- GNLX 54.19
- Support Level
- VGI $7.50
- GNLX $2.87
- Resistance Level
- VGI $7.73
- GNLX $3.17
- Average True Range (ATR)
- VGI 0.06
- GNLX 0.24
- MACD
- VGI 0.01
- GNLX 0.01
- Stochastic Oscillator
- VGI 100.00
- GNLX 51.97
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.